Our Trusts Fundraising Manager, Nicola Shaw, pays tribute to the family charity partners who make our vital research possible.
The parents of Isabella Ortiz, who died from a brain tumour, have highlighted the need for rare tissue donation, to help other children facing the same condition.
Sally is 40 and living with stage 4 cancer. Help us kick-start our vital research so that patients like Sally can live well with cancer.
A virtual run has been launched in the UK inspired by a prominent Canadian cancer research activist, to raise money for the Institute of Cancer Research, London.
The LGBT+ network at the ICR and The Royal Marsden is celebrating Pride a little differently this year.
Christine is being treated for secondary breast cancer with the innovative new drug palbociclib.
Dr George Poulogiannis and colleagues found that targeting cancer’s ability to process fat using a new class of drugs could halt tumour growth in mice, but only when combined with a diet free of fats.
Thanks to abiraterone – a drug discovered and developed by the ICR – Rob’s been living well with prostate cancer for seven and a half years.
Professor Ian Collins talks about our drug discovery work - including the formation of a new spinout company.